» Articles » PMID: 34307123

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Jul 26
PMID 34307123
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Radiomics is an emerging field in radiology that utilizes advanced statistical data characterizing algorithms to evaluate medical imaging and objectively quantify characteristics of a given disease. Due to morphologic heterogeneity and genetic variation intrinsic to neoplasms, radiomics have the potential to provide a unique insight into the underlying tumor and tumor microenvironment. Radiomics has been gaining popularity due to potential applications in disease quantification, predictive modeling, treatment planning, and response assessment - paving way for the advancement of personalized medicine. However, producing a reliable radiomic model requires careful evaluation and construction to be translated into clinical practices that have varying software and/or medical equipment. We aim to review the diagnostic utility of radiomics in otorhinolaryngology, including both cancers of the head and neck as well as the thyroid.

Citing Articles

CT-based radiomics features for the differential diagnosis of nodular goiter and papillary thyroid carcinoma: an analysis employing propensity score matching.

Zhang H, Li Z, Zhang F, Li H Front Oncol. 2024; 14:1465941.

PMID: 39726704 PMC: 11669662. DOI: 10.3389/fonc.2024.1465941.


Radiomics-Based Analysis in the Prediction of Occult Lymph Node Metastases in Patients with Oral Cancer: A Systematic Review.

Jiang S, Locatello L, Maggiore G, Gallo O J Clin Med. 2023; 12(15).

PMID: 37568363 PMC: 10419487. DOI: 10.3390/jcm12154958.


Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review.

Dondi F, Gatta R, Treglia G, Piccardo A, Albano D, Camoni L Rev Endocr Metab Disord. 2023; 25(1):175-186.

PMID: 37434097 PMC: 10808150. DOI: 10.1007/s11154-023-09822-4.


The progress of radiomics in thyroid nodules.

Gao X, Ran X, Ding W Front Oncol. 2023; 13:1109319.

PMID: 36959790 PMC: 10029726. DOI: 10.3389/fonc.2023.1109319.


Radiomics Features of Different Sizes of Medullary Thyroid Carcinoma (MTC) and Papillary Thyroid Carcinoma (PTC) Tumors: A Comparative Study.

Zhao L, Ma B Clin Med Insights Oncol. 2022; 16:11795549221097675.

PMID: 35603093 PMC: 9121460. DOI: 10.1177/11795549221097675.


References
1.
Lapa C, Werner R, Schmid J, Papp L, Zsoter N, Biko J . Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy. Nucl Med Biol. 2015; 42(4):349-54. DOI: 10.1016/j.nucmedbio.2014.12.006. View

2.
Cohen N, Fedewa S, Chen A . Epidemiology and Demographics of the Head and Neck Cancer Population. Oral Maxillofac Surg Clin North Am. 2018; 30(4):381-395. DOI: 10.1016/j.coms.2018.06.001. View

3.
Avanzo M, Stancanello J, El Naqa I . Beyond imaging: The promise of radiomics. Phys Med. 2017; 38:122-139. DOI: 10.1016/j.ejmp.2017.05.071. View

4.
Zhang B, Tian J, Dong D, Gu D, Dong Y, Zhang L . Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma. Clin Cancer Res. 2017; 23(15):4259-4269. DOI: 10.1158/1078-0432.CCR-16-2910. View

5.
Brown A, Nagala S, McLean M, Lu Y, Scoffings D, Apte A . Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med. 2015; 75(4):1708-16. PMC: 4654719. DOI: 10.1002/mrm.25743. View